Growth Opportunity Nabsys has a growing footprint with plans to expand their headquarters to Providence, Rhode Island and has signaled significant hiring momentum. This indicates an expanding sales outreach window for lab instrumentation, software licenses, and service contracts aligned with their OhmX platform needs and long-read SV analysis workflows.

Hematologic Focus Recent news highlights collaboration and development efforts around hematologic malignancies. This presents a sales opportunity to position EGM solutions for disease-specific SV detection, copy number analysis, and integration with hematology workflows in academic centers and hospitals.

End-to-End Solution OhmX platform offers end-to-end genome mapping from sample prep to analytics with a web-based UI. This creates a chance to upsell workflow optimization services, automated monitoring, data analytics modules, and professional services for deployment, training, and ongoing support.

Cost and Footprint Low instrument and consumable costs, along with a compact system footprint, position Nabsys well for cost-conscious labs and small to mid-sized biotechs expanding SV analysis capacity. Target these segments with maintenance plans, consumables pipelines, and scalable licensing options.

Strategic Partnerships Active collaborations with academic institutions (Indiana University) and industry awareness at cancer genomics events suggest readiness for co-development, joint grant opportunities, and funded studies. Leverage these ties to propose co-funded pilots, research collaborations, and sponsored studies.